Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma Miki KiyotaTsutomu KobayashiShinichi FuchidaMio Yamamoto-SugitaniMuneo Ohshiro • Yuji ShimuraShinsuke MizutaniHisao NagoshiNana SasakiRyuko NakayamaYoshiaki Chinen • Natsumi SakamotoHitoji UchiyamaYosuke MatsumotoShigeo HoriikeChihiro Shimazaki •
Year: 2012
Type: article
Study design: Observational Study
Author: Junya KurodaMasafumi Taniwaki
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2560628459
